Taken together, these findings indicate that, in the context of bleomycin treatment, although Klf4 deletion in PDGFR-β+ cells attenuates lung fibrosis, KLF4 is not required for PDGFR-β+ cell proliferation or differentiation into myofibroblasts. This evidence concerns the gene KLF4 and pulmonary fibrosis.